These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1705630)

  • 21. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
    Schnecko A; Witte K; Lemmer B
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antihypertensive mechanism of delapril, a newly developed converting enzyme inhibitor, is related to the suppression of vascular angiotensin II release in the spontaneously hypertensive rat.
    Mizuno K; Tani M; Niimura S; Yamaguchi M; Inagami T; Fukuchi S
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):60S-66S. PubMed ID: 2009151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.
    Tokioka T; Shibasaki M; Fujimori A; Matsuda-Satoh Y; Uchida W; Inagaki O; Yanagisawa I
    Biol Pharm Bull; 2000 Feb; 23(2):174-81. PubMed ID: 10706380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
    Wong PC; Quan ML; Saye JM; Bernard R; Crain EJ; McCall DE; Watson CA; Zaspel AM; Smith RD; Wexler RR
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):354-62. PubMed ID: 8583775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exaggerated pressor response to centrally administered renin in freely moving, spontaneously hypertensive rats.
    Kawasaki H; Takasaki K; Furukawa T
    Eur J Pharmacol; 1987 Jun; 138(3):351-7. PubMed ID: 3305043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
    Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
    J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
    Guan H; Cachofeiro V; Pucci ML; Kaminski PM; Wolin MS; Nasjletti A
    Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential response of angiotensin peptides in the urine of hypertensive animals.
    Yamada K; Iyer SN; Chappell MC; Brosnihan KB; Fukuhara M; Ferrario CM
    Regul Pept; 1999 Mar; 80(1-2):57-66. PubMed ID: 10235635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Converting enzyme inhibitors and brain angiotensin.
    Phillips MI; Kimura B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S82-90. PubMed ID: 2438497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
    Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S
    Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic profile of TA-606, a novel angiotensin II-receptor antagonist in the rat.
    Hashimoto Y; Ohashi R; Kurosawa Y; Minami K; Kaji H; Hayashida K; Narita H; Murata S
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):568-75. PubMed ID: 9554806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS; Sharifi AM; Schiffrin EL
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of low dose angiotension hypertension by angiotensin receptor antagonists.
    Smits GJ; Koepke JP; Blaine EH
    Hypertension; 1991 Jul; 18(1):17-21. PubMed ID: 1860708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
    Allan DR; Hui KY; Coletti C; Hollenberg NK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K; Morishita R; Moriguchi A; Tomita N; Yo Y; Nishii T; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
    Paula RD; Lima CV; Khosla MC; Santos RA
    Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.